Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia.
about
Atypical protein kinase C in cardiometabolic abnormalitiesInhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In VitroDiacylglycerol kinase zeta in hypothalamus interacts with long form leptin receptor. Relation to dietary fat and body weight regulationRegulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2Deletion of PKCepsilon selectively enhances the amplifying pathways of glucose-stimulated insulin secretion via increased lipolysis in mouse beta-cellsInhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseObesity is associated with impaired ventricular protein kinase C-MAP kinase signaling and altered ANP mRNA expression in the heart of adult Zucker ratsRegulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: role of serine 24 phosphorylationMechanisms for insulin resistance: common threads and missing linksEffect of diacylglycerol acyltransferase 2 overexpression in 3T3-L1 is associated to an increase in mono-unsaturated fatty acid accumulation.Signaling pathways in insulin action: molecular targets of insulin resistanceProtein kinase C activation and its pharmacological inhibition in vascular disease.AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.Disordered lipid metabolism and the pathogenesis of insulin resistance.Protein kinase C and the development of diabetic vascular complications.Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity.Cellular mechanism of insulin resistance in nonalcoholic fatty liver diseaseInsulin resistance induced by hyperinsulinemia coincides with a persistent alteration at the insulin receptor tyrosine kinase domain.Hepatic Atypical Protein Kinase C: An Inherited Survival-Longevity Gene that Now Fuels Insulin-Resistant Syndromes of Obesity, the Metabolic Syndrome and Type 2 Diabetes MellitusProtein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes.Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.Liver and diabetes. A vicious circle.Loss of protein kinase Cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance.Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance.The tail wagging the dog--regulation of lipid metabolism by protein kinase C.Coordinated phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 and protein kinase C betaII in the diabetic fat tissue.Dietary phospholipids ameliorate fructose-induced hepatic lipid and metabolic abnormalities in rats.Inhibition of cellular responses to insulin in a rat liver cell line. A role for PKC in insulin resistance.Transcriptional regulation of insulin receptor substrate 1 by protein kinase C.Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.Protein kinase C modulates insulin action in human skeletal muscle.Protein kinase C isoforms epsilon, eta, delta and zeta in murine adipocytes: expression, subcellular localization and tissue-specific regulation in insulin-resistant states.Inhibitory effect of hypocrellin A on protein kinase C in liver and skeletal muscle of obese Zucker rats.Shp2 is required for protein kinase C-dependent phosphorylation of serine 307 in insulin receptor substrate-1.Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle.Protein kinase C-alpha and -epsilon down-regulate cell surface sodium channels via differential mechanisms in adrenal chromaffin cells.Carbon tetrachloride-induced hepatic injury through formation of oxidized diacylglycerol and activation of the PKC/NF-κB pathway.Time-dependent effects of Prkce deletion on glucose homeostasis and hepatic lipid metabolism on dietary lipid oversupply in mice.Altered hepatic insulin signalling in male offspring of obese mice.
P2860
Q27026092-C2607A78-B5FF-4A07-9DA7-EE1EAF76CEB2Q27324561-5B38DA3C-5E3F-4733-B84A-803470C4820CQ28143849-E43F0245-10F6-4605-A334-8A86B5919AFBQ28272571-501BE2EC-AA1F-43F0-BC48-5D8641F5A2BFQ28506519-CB460506-4AA4-49B7-BC25-0A0A1BAB84E0Q28571421-76696AB8-7766-4C15-9E0D-E8E004AC40F9Q28579107-D67CC017-2F55-4BEE-B605-FEC31B6C3169Q28581138-E816DF8D-51B6-4A83-99BF-3DFF4426ABE1Q29620447-48583C06-56AB-4FB0-B628-60583D13CE8AQ33824420-BB7F00B6-7534-4727-B821-904441B5E539Q33973814-5685A36F-1586-43F9-A974-C7A3FE8CDDDBQ34097328-437B8CBA-C8B8-45C4-AB27-B8F6A27B1F09Q34310675-40E91E87-209A-4751-90C8-E5ED63FA0647Q34370965-646B9845-9DB2-4AAF-9B25-F5AD818996F5Q34570516-8040A3AC-85A4-45EC-820D-835C55A0A513Q34571695-4E8B0BF0-A0E6-4FDE-87D6-A65F2404EF45Q35239565-A3EFBE7F-2392-4D67-96AE-5A0346B36222Q35279453-240D2862-573D-493C-BBA0-503129C1576CQ35667136-62DCA830-AFD4-49CF-A74A-829EE4717A02Q36756469-061108D0-2F89-4DE7-84AB-409F9C891E8CQ37023053-C5AEFF65-0C29-4731-940A-B912668CAEFCQ37070333-53B49FC3-3283-4177-B0DD-47265D4109E0Q37308701-168C6E13-8C0D-435F-A99A-07ADDB143F7AQ37375539-35880D00-6A01-4B71-8645-25A09DB9C10BQ37822940-72F0C298-3DFB-4C5E-ACC7-09A2C8746447Q38099064-2D697DF5-43AD-4367-88C8-E7F16F21DC3FQ38291546-C900BE71-B6D6-49CC-B17E-B6804EE29F3FQ39469609-791140F8-155D-44AA-8533-7A5842358D71Q40471512-04F0F9A3-1226-4442-927F-A90C6834D207Q41145396-77F0A2B1-6E41-467F-908A-82E2A848AF85Q42033681-6BF4B44D-0DEF-4CEF-BD8C-C0FE7715F57EQ42484748-DDD6B38F-B4C0-4394-9A3D-718122C345B4Q42737842-542BB20E-99E5-426A-835E-A128F38174A2Q44781647-349C9824-1A9F-4169-840F-EE4E2851CDCEQ46627912-5B29ADF9-236A-4569-994F-CD13B9DB65DCQ51118064-FDE80DA4-942E-473C-961C-2791B7C36BE7Q51409729-30815E1B-0C6F-4F01-A029-6732F2F36DBDQ54468023-9D100910-1D76-44A2-9FAA-598E43E6F60DQ54610576-DAC1AA1D-23D5-4BE1-B384-DB0FDB8F3CD4Q54671549-5529C198-A65E-4B0A-9D88-DD6BA5822D6E
P2860
Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Protein kinase C is increased ...... tion not due to hyperglycemia.
@ast
Protein kinase C is increased ...... tion not due to hyperglycemia.
@en
Protein kinase C is increased ...... tion not due to hyperglycemia.
@nl
type
label
Protein kinase C is increased ...... tion not due to hyperglycemia.
@ast
Protein kinase C is increased ...... tion not due to hyperglycemia.
@en
Protein kinase C is increased ...... tion not due to hyperglycemia.
@nl
prefLabel
Protein kinase C is increased ...... tion not due to hyperglycemia.
@ast
Protein kinase C is increased ...... tion not due to hyperglycemia.
@en
Protein kinase C is increased ...... tion not due to hyperglycemia.
@nl
P2093
P2860
P356
P1476
Protein kinase C is increased ...... tion not due to hyperglycemia.
@en
P2093
L M Morales
R V Considine
S Lanza-Jacoby
S Triester
P2860
P304
P356
10.1172/JCI118001
P407
P577
1995-06-01T00:00:00Z